For: | Dharmapuri S, Özbek U, Jethra H, Jun T, Marron TU, Saeed A, Huang YH, Muzaffar M, Pinter M, Balcar L, Fulgenzi C, Amara S, Weinmann A, Personeni N, Scheiner B, Pressiani T, Navaid M, Bengsch B, Paul S, Khan U, Bettinger D, Nishida N, Mohamed YI, Vogel A, Gampa A, Korolewicz J, Cammarota A, Kaseb A, Galle PR, Pillai A, Wang YH, Cortellini A, Kudo M, D’Alessio A, Rimassa L, Pinato DJ, Ang C. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(11): 1900-1912 [PMID: 38077640 DOI: 10.4251/wjgo.v15.i11.1900] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1900.htm |
Number | Citing Articles |
1 |
Qiu-Yu Jiang, Ru-Yi Xue. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: Markers predicting immune-checkpoint inhibitor efficacy and immune-related adverse events. World Journal of Gastrointestinal Oncology 2024; 16(3): 577-582 doi: 10.4251/wjgo.v16.i3.577
Abstract(115) |
Core Tip(105) |
Full Article(HTML)(703)
|
Full Article with Cover (PDF)-650K(19)
|
Full Article (Word)-119K(0)
|
Audio-472K(5)
|
Peer-Review Report-215K(14)
|
Answering Reviewers-117K(12)
|
Full Article (PDF)-382K(31)
|
Full Article (XML)-145K(19)
|
Times Cited (0)
|
Total Visits (1238)
|
Open
|
2 |
Ben Ponvilawan, Abdul Wali Khan, Janakiraman Subramanian, Dhruv Bansal. Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors. Cancers 2024; 16(6): 1225 doi: 10.3390/cancers16061225
|
3 |
Zhenli Li, Tiezhu Yao, Guang Liu, Zhengkun Guan, Jing Liu, Ling Guo, Jingtao Ma. Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05801-7
|